Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
University of Washington
University of Washington
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
The University of Texas Health Science Center at San Antonio
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fate Therapeutics
Weill Medical College of Cornell University
ADC Therapeutics S.A.
University of Washington
Celgene
UNC Lineberger Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
National Cancer Institute (NCI)
University of California, San Francisco
Northwestern University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)